Sandra Jeanne Langley, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 416 S Main St, Estill Springs, TN 37330 Phone: 931-649-3408 Fax: 931-649-3409 |
News Archive
Researchers have identified a protein that reins in the rogue activity of the molecules that make the amyloid-beta protein-which may prevent normal brain function in people with Alzheimer's disease. Their findings reveal a potentially powerful tool for designing novel Alzheimer's treatments.
The recent ability to peer into the brain of living individuals with a rare type of language dementia, primary progressive aphasia (PPA), provides important new insights into the beginning stages of this disease - which results in language loss - when it is caused by a buildup of a toxic protein found in Alzheimer's disease.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
Social media has become an important way for institutions to communicate - both sending messages and receiving feedback - with clients and with the general public.
› Verified 7 days ago